Optimizing Hepatitis B Vaccine Response Through the Use of a Topical Immune Modulator

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2005
This study will look at what happens to the level of protection against hepatitis B (HB) disease if a \'helper\' gel is applied to the skin over the injection site of a small dose of hepatitis B vaccine.
Epistemonikos ID: 0bef836b313c924d0d6d59d4468c33befc441514
First added on: Nov 24, 2021